Arrowhead Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Arrowhead Pharmaceuticals patents 50 in total
| Status | Patent |
|---|---|
Application | Utility: RNAi Inhibition of Alpha-ENaC Expression Filling date: 8 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: RNAi Agents for Inhibiting Expression of HIF-2 alpha (EPAS1), Compositions Thereof, and Methods of Use Filling date: 8 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: ALPHA-1 ANTITRYPSIN (AAT) RNAI AGENTS, COMPOSITIONS INCLUDING AAT RNAI AGENTS, AND METHODS OF USE Filling date: 8 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Filling date: 8 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: Methods For The Treatment Of APOC3-Related Diseases And Disorders Filling date: 8 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: 5'-Cyclo-Phosphonate Modified Nucleotides Filling date: 8 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: RNAi Inhibition of Alpha-ENaC Expression Filling date: 8 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: RNAi Agents for Inhibiting Expression of Alpha-ENaC And Methods of Use Filling date: 8 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: RNAI AGENTS FOR HEPATITIS B VIRUS INFECTION Filling date: 8 Sep 2025 Issue date: 17 Mar 2022 |
Application | Utility: RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3) Filling date: 8 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: RNAi Agents for Inhibiting Expression of 17beta-HSD Type 13 (HSD17B13), Compositions Thereof, and Methods of Use Filling date: 8 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Filling date: 8 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: Targeting Ligands Filling date: 8 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: ALPHA-V BETA-6 INTEGRIN LIGANDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: RNAI AGENTS FOR HEPATITIS B VIRUS INFECTION Filling date: 8 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: RNAi Agents For Inhibiting Expression Of PNPLA3, Pharmaceutical Compositions Thereof, And Methods Of Use Filling date: 8 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: RNAi Agents And Compositions for Inhibiting Expression of Angiopoietin-Like 3 (ANGPTL3), And Methods Of Use Filling date: 8 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Filling date: 8 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: Targeting Ligands For Therapeutic Compounds Filling date: 8 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: Compositions and Methods for Inhibiting Gene Expression of Hif2alpha Filling date: 8 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Filling date: 8 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: RNAI AGENTS FOR HEPATITIS B VIRUS INFECTION Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: INTEGRIN TARGETING LIGANDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: INTEGRIN TARGETING LIGANDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: RNAI THERAPY FOR HEPATITIS B VIRUS INFECTION Filling date: 8 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Filling date: 8 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: INTEGRIN LIGANDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: RNAi Agents for Inhibiting Expression of Alpha-ENaC And Methods of Use Filling date: 8 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3) Filling date: 8 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: RNAi Agents And Compositions for Inhibiting Expression of Asiaglycoprotein Receptor 1 Filling date: 8 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Filling date: 8 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: Compositions and Methods for Inhibiting Expression of RRM2 Genes Filling date: 8 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF LPA Filling date: 8 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: Alpha-1 AntiTrypsin (AAT) RNAi Agents, Compositions Including AAT RNAi Agents, And Methods of Use Filling date: 8 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: ORGANIC COMPOSITIONS TO TREAT EPAS1-RELATED DISEASES Filling date: 8 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Filling date: 8 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: RNAi Inhibition of Alpha-ENaC Expression Filling date: 8 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Filling date: 8 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: Compositions and Methods for Inhibition of Factor XII Gene Expression Filling date: 8 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: Compositions and Methods for Inhibiting Gene Expression of Factor XII Filling date: 8 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Filling date: 8 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES Filling date: 8 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: RNAi Agents for Hepatitis B Virus Infection Filling date: 8 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: Compositions and Methods for Inhibiting Gene Expression of Alpha-1 AntiTrypsin Filling date: 8 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES Filling date: 8 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Filling date: 8 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: Targeting Ligands Filling date: 8 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: RNAi AGENTS FOR HEPATITIS B VIRUS INFECTION Filling date: 8 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: ALPHA-V BETA-6 INTEGRIN LIGANDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: ORGANIC COMPOSITIONS TO TREAT APOC3-RELATED DISEASES Filling date: 8 Sep 2025 Issue date: 1 Aug 2019 |
Showing 1 to 50 of 50 patents.